Global Epigenomic Market Research Report 2023

Epigenomics is the study of the complete set of epigenetic modifications on the genetic material of a cell, known as the epigenome. The field is analogous to genomics and proteomics, which are the study of the genome and proteome of a cell.

The global Epigenomic market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

North American market for Epigenomic is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

Asia-Pacific market for Epigenomic is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The global market for Epigenomic in Research Institution is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The key global companies of Epigenomic include Roche Diagnostics, Thermo Fisher Scientific, Eisai and Novartis, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Epigenomic, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Epigenomic.

The Epigenomic market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Epigenomic market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Epigenomic companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Epigenomic Market Size Growth Rate by Type: 2018 VS 2022 VS 2029

1.2.2 Reagents

1.2.3 Kits

1.2.4 Instruments

1.2.5 Services

1.3 Market by Application

1.3.1 Global Epigenomic Market Growth by Application: 2018 VS 2022 VS 2029

1.3.2 Research Institution

1.3.3 Hospital

1.3.4 Others

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2.1 Global Epigenomic Market Perspective (2018-2029)

2.2 Epigenomic Growth Trends by Region

2.2.1 Global Epigenomic Market Size by Region: 2018 VS 2022 VS 2029

2.2.2 Epigenomic Historic Market Size by Region (2018-2023)

2.2.3 Epigenomic Forecasted Market Size by Region (2024-2029)

2.3 Epigenomic Market Dynamics

2.3.1 Epigenomic Industry Trends

2.3.2 Epigenomic Market Drivers

2.3.3 Epigenomic Market Challenges

2.3.4 Epigenomic Market Restraints

3.1 Global Top Epigenomic Players by Revenue

3.1.1 Global Top Epigenomic Players by Revenue (2018-2023)

3.1.2 Global Epigenomic Revenue Market Share by Players (2018-2023)

3.2 Global Epigenomic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Epigenomic Revenue

3.4 Global Epigenomic Market Concentration Ratio

3.4.1 Global Epigenomic Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Epigenomic Revenue in 2022

3.5 Epigenomic Key Players Head office and Area Served

3.6 Key Players Epigenomic Product Solution and Service

3.7 Date of Enter into Epigenomic Market

3.8 Mergers & Acquisitions, Expansion Plans

4.1 Global Epigenomic Historic Market Size by Type (2018-2023)

4.2 Global Epigenomic Forecasted Market Size by Type (2024-2029)

5.1 Global Epigenomic Historic Market Size by Application (2018-2023)

5.2 Global Epigenomic Forecasted Market Size by Application (2024-2029)

6.1 North America Epigenomic Market Size (2018-2029)

6.2 North America Epigenomic Market Growth Rate by Country: 2018 VS 2022 VS 2029

6.3 North America Epigenomic Market Size by Country (2018-2023)

6.4 North America Epigenomic Market Size by Country (2024-2029)

6.5 United States

6.6 Canada

7.1 Europe Epigenomic Market Size (2018-2029)

7.2 Europe Epigenomic Market Growth Rate by Country: 2018 VS 2022 VS 2029

7.3 Europe Epigenomic Market Size by Country (2018-2023)

7.4 Europe Epigenomic Market Size by Country (2024-2029)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8.1 Asia-Pacific Epigenomic Market Size (2018-2029)

8.2 Asia-Pacific Epigenomic Market Growth Rate by Region: 2018 VS 2022 VS 2029

8.3 Asia-Pacific Epigenomic Market Size by Region (2018-2023)

8.4 Asia-Pacific Epigenomic Market Size by Region (2024-2029)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9.1 Latin America Epigenomic Market Size (2018-2029)

9.2 Latin America Epigenomic Market Growth Rate by Country: 2018 VS 2022 VS 2029

9.3 Latin America Epigenomic Market Size by Country (2018-2023)

9.4 Latin America Epigenomic Market Size by Country (2024-2029)

9.5 Mexico

9.6 Brazil

10.1 Middle East & Africa Epigenomic Market Size (2018-2029)

10.2 Middle East & Africa Epigenomic Market Growth Rate by Country: 2018 VS 2022 VS 2029

10.3 Middle East & Africa Epigenomic Market Size by Country (2018-2023)

10.4 Middle East & Africa Epigenomic Market Size by Country (2024-2029)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11.1 Roche Diagnostics

11.1.1 Roche Diagnostics Company Detail

11.1.2 Roche Diagnostics Business Overview

11.1.3 Roche Diagnostics Epigenomic Introduction

11.1.4 Roche Diagnostics Revenue in Epigenomic Business (2018-2023)

11.1.5 Roche Diagnostics Recent Development

11.2 Thermo Fisher Scientific

11.2.1 Thermo Fisher Scientific Company Detail

11.2.2 Thermo Fisher Scientific Business Overview

11.2.3 Thermo Fisher Scientific Epigenomic Introduction

11.2.4 Thermo Fisher Scientific Revenue in Epigenomic Business (2018-2023)

11.2.5 Thermo Fisher Scientific Recent Development

11.3 Eisai

11.3.1 Eisai Company Detail

11.3.2 Eisai Business Overview

11.3.3 Eisai Epigenomic Introduction

11.3.4 Eisai Revenue in Epigenomic Business (2018-2023)

11.3.5 Eisai Recent Development

11.4 Novartis

11.4.1 Novartis Company Detail

11.4.2 Novartis Business Overview

11.4.3 Novartis Epigenomic Introduction

11.4.4 Novartis Revenue in Epigenomic Business (2018-2023)

11.4.5 Novartis Recent Development

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

List of Tables

    Table 1. Global Epigenomic Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029

    Table 2. Key Players of Reagents

    Table 3. Key Players of Kits

    Table 4. Key Players of Instruments

    Table 5. Key Players of Services

    Table 6. Global Epigenomic Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029

    Table 7. Global Epigenomic Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 8. Global Epigenomic Market Size by Region (2018-2023) & (US$ Million)

    Table 9. Global Epigenomic Market Share by Region (2018-2023)

    Table 10. Global Epigenomic Forecasted Market Size by Region (2024-2029) & (US$ Million)

    Table 11. Global Epigenomic Market Share by Region (2024-2029)

    Table 12. Epigenomic Market Trends

    Table 13. Epigenomic Market Drivers

    Table 14. Epigenomic Market Challenges

    Table 15. Epigenomic Market Restraints

    Table 16. Global Epigenomic Revenue by Players (2018-2023) & (US$ Million)

    Table 17. Global Epigenomic Market Share by Players (2018-2023)

    Table 18. Global Top Epigenomic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Epigenomic as of 2022)

    Table 19. Ranking of Global Top Epigenomic Companies by Revenue (US$ Million) in 2022

    Table 20. Global 5 Largest Players Market Share by Epigenomic Revenue (CR5 and HHI) & (2018-2023)

    Table 21. Key Players Headquarters and Area Served

    Table 22. Key Players Epigenomic Product Solution and Service

    Table 23. Date of Enter into Epigenomic Market

    Table 24. Mergers & Acquisitions, Expansion Plans

    Table 25. Global Epigenomic Market Size by Type (2018-2023) & (US$ Million)

    Table 26. Global Epigenomic Revenue Market Share by Type (2018-2023)

    Table 27. Global Epigenomic Forecasted Market Size by Type (2024-2029) & (US$ Million)

    Table 28. Global Epigenomic Revenue Market Share by Type (2024-2029)

    Table 29. Global Epigenomic Market Size by Application (2018-2023) & (US$ Million)

    Table 30. Global Epigenomic Revenue Market Share by Application (2018-2023)

    Table 31. Global Epigenomic Forecasted Market Size by Application (2024-2029) & (US$ Million)

    Table 32. Global Epigenomic Revenue Market Share by Application (2024-2029)

    Table 33. North America Epigenomic Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 34. North America Epigenomic Market Size by Country (2018-2023) & (US$ Million)

    Table 35. North America Epigenomic Market Size by Country (2024-2029) & (US$ Million)

    Table 36. Europe Epigenomic Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 37. Europe Epigenomic Market Size by Country (2018-2023) & (US$ Million)

    Table 38. Europe Epigenomic Market Size by Country (2024-2029) & (US$ Million)

    Table 39. Asia-Pacific Epigenomic Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 40. Asia-Pacific Epigenomic Market Size by Region (2018-2023) & (US$ Million)

    Table 41. Asia-Pacific Epigenomic Market Size by Region (2024-2029) & (US$ Million)

    Table 42. Latin America Epigenomic Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 43. Latin America Epigenomic Market Size by Country (2018-2023) & (US$ Million)

    Table 44. Latin America Epigenomic Market Size by Country (2024-2029) & (US$ Million)

    Table 45. Middle East & Africa Epigenomic Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 46. Middle East & Africa Epigenomic Market Size by Country (2018-2023) & (US$ Million)

    Table 47. Middle East & Africa Epigenomic Market Size by Country (2024-2029) & (US$ Million)

    Table 48. Roche Diagnostics Company Detail

    Table 49. Roche Diagnostics Business Overview

    Table 50. Roche Diagnostics Epigenomic Product

    Table 51. Roche Diagnostics Revenue in Epigenomic Business (2018-2023) & (US$ Million)

    Table 52. Roche Diagnostics Recent Development

    Table 53. Thermo Fisher Scientific Company Detail

    Table 54. Thermo Fisher Scientific Business Overview

    Table 55. Thermo Fisher Scientific Epigenomic Product

    Table 56. Thermo Fisher Scientific Revenue in Epigenomic Business (2018-2023) & (US$ Million)

    Table 57. Thermo Fisher Scientific Recent Development

    Table 58. Eisai Company Detail

    Table 59. Eisai Business Overview

    Table 60. Eisai Epigenomic Product

    Table 61. Eisai Revenue in Epigenomic Business (2018-2023) & (US$ Million)

    Table 62. Eisai Recent Development

    Table 63. Novartis Company Detail

    Table 64. Novartis Business Overview

    Table 65. Novartis Epigenomic Product

    Table 66. Novartis Revenue in Epigenomic Business (2018-2023) & (US$ Million)

    Table 67. Novartis Recent Development

    Table 68. Research Programs/Design for This Report

    Table 69. Key Data Information from Secondary Sources

    Table 70. Key Data Information from Primary Sources

List of Figures

    Figure 1. Global Epigenomic Market Size Comparison by Type (2023-2029) & (US$ Million)

    Figure 2. Global Epigenomic Market Share by Type: 2022 VS 2029

    Figure 3. Reagents Features

    Figure 4. Kits Features

    Figure 5. Instruments Features

    Figure 6. Services Features

    Figure 7. Global Epigenomic Market Size Comparison by Application (2023-2029) & (US$ Million)

    Figure 8. Global Epigenomic Market Share by Application: 2022 VS 2029

    Figure 9. Research Institution Case Studies

    Figure 10. Hospital Case Studies

    Figure 11. Others Case Studies

    Figure 12. Epigenomic Report Years Considered

    Figure 13. Global Epigenomic Market Size (US$ Million), Year-over-Year: 2018-2029

    Figure 14. Global Epigenomic Market Size, (US$ Million), 2018 VS 2022 VS 2029

    Figure 15. Global Epigenomic Market Share by Region: 2022 VS 2029

    Figure 16. Global Epigenomic Market Share by Players in 2022

    Figure 17. Global Top Epigenomic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Epigenomic as of 2022)

    Figure 18. The Top 10 and 5 Players Market Share by Epigenomic Revenue in 2022

    Figure 19. North America Epigenomic Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 20. North America Epigenomic Market Share by Country (2018-2029)

    Figure 21. United States Epigenomic Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 22. Canada Epigenomic Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 23. Europe Epigenomic Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 24. Europe Epigenomic Market Share by Country (2018-2029)

    Figure 25. Germany Epigenomic Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 26. France Epigenomic Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 27. U.K. Epigenomic Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 28. Italy Epigenomic Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 29. Russia Epigenomic Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 30. Nordic Countries Epigenomic Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 31. Asia-Pacific Epigenomic Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 32. Asia-Pacific Epigenomic Market Share by Region (2018-2029)

    Figure 33. China Epigenomic Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 34. Japan Epigenomic Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 35. South Korea Epigenomic Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 36. Southeast Asia Epigenomic Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 37. India Epigenomic Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 38. Australia Epigenomic Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 39. Latin America Epigenomic Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 40. Latin America Epigenomic Market Share by Country (2018-2029)

    Figure 41. Mexico Epigenomic Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 42. Brazil Epigenomic Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 43. Middle East & Africa Epigenomic Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 44. Middle East & Africa Epigenomic Market Share by Country (2018-2029)

    Figure 45. Turkey Epigenomic Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 46. Saudi Arabia Epigenomic Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 47. Roche Diagnostics Revenue Growth Rate in Epigenomic Business (2018-2023)

    Figure 48. Thermo Fisher Scientific Revenue Growth Rate in Epigenomic Business (2018-2023)

    Figure 49. Eisai Revenue Growth Rate in Epigenomic Business (2018-2023)

    Figure 50. Novartis Revenue Growth Rate in Epigenomic Business (2018-2023)

    Figure 51. Bottom-up and Top-down Approaches for This Report

    Figure 52. Data Triangulation

    Figure 53. Key Executives Interviewed